A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up

2010 ◽  
Vol 105 (7) ◽  
pp. 964-969 ◽  
Author(s):  
David M. Bouchier-Hayes ◽  
Scott Van Appledorn ◽  
Pat Bugeja ◽  
Helen Crowe ◽  
Ben Challacombe ◽  
...  
2012 ◽  
Vol 6 (2) ◽  
Author(s):  
Justin X.G. Zhu ◽  
Manal Y. Gabril ◽  
Alp Sener

The use of lasers to perform photoselective vaporization of the prostate (PVP) has been widely accepted as a safe and effectivetreatment for benign prostatic hyperplasia with very few reported complications. To date, most of the published data report outcomesfor the 80-W potassium-titanyl-phosphate laser. A more potent laser, the 120-W GreenLight HPS, was introduced in 2006 and provides more efficient vaporization of prostatic tissue anddecreased operating times. Despite these benefits, the increased energy applied to the prostate evokes concerns of potential serious complications, including capsular perforation and injury to adjacent structures. A more powerful laser system, the 180-WGreenLight XPS laser (American Medical Systems, Minnetonka, MN) has recently become available. We report a rare but serious complication of GreenLight HPS PVP resulting in prostatic capsularperforation with urinary extravasation, presenting with bilateral thigh urinomas and osteitis pubis.


2008 ◽  
Vol 179 (4S) ◽  
pp. 630-630 ◽  
Author(s):  
David M Bouchier-Hayes ◽  
Scott Van Appledorn ◽  
Patrick J O'Malley ◽  
Pat Bugeja ◽  
Anthony J Costello

Sign in / Sign up

Export Citation Format

Share Document